Radiation and Immunotherapy Combination Shows Promise for HNSCC Treatment
A combination of radiation therapy and immunotherapy may lead to encouraging survival outcomes and acceptable toxicity for patients with locally advanced head and.
Industry News
Industry News
Checkpoint Inhibitor Increases Head and Neck Cancer Survival Time
The checkpoint inhibitor pembrolizumab (Keytruda) offers patients with advanced head and neck cancers longer survival time, according to researchers led by the Yale.
Industry News
Rocker Beats Oral Cancer with Immunotherapy
Rikki Rockett, drummer with the rock band Poison, was diagnosed with oral cancer a little more than a year ago. Now, the tumor.
